Boston Scientific Corporation
BSX
Kedudukan dalam Saham
#409
Penerangan syarikat ini hanya tersedia dalam bahasa Inggeris.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Harga Saham
$41.88
Disegerakkan terakhir: 2026-10-30
Modal Pasaran
$60.69B
Perubahan (1 hari)
-1.89%
Perubahan (1 tahun)
-58.42%
Negara
US
Data saham: Financial Modeling PrepΒ·Dikemas kini Β·Bukan nasihat pelaburanΒ·Cara kami mengira
Perdagangan Boston Scientific Corporation (BSX)
Kategori
Healthcare
Bilangan saham terbitan bagi Boston Scientific Corporation (BSX)
Bilangan saham terbitan setakat September 2026: 1.45B
Menurut laporan kewangan terkini dan harga saham Boston Scientific Corporation, bilangan saham terbitan semasa ialah 1.45B. Pada akhir 2025, syarikat mempunyai 1.48B saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Boston Scientific Corporation (BSX) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Perubahan |
|---|---|---|
| 2026 (TTM) | 1.45B | -2.14% |
| 2025 | 1.48B | 0.60% |
| 2024 | 1.47B | 1.27% |
| 2023 | 1.45B | 1.57% |
| 2022 | 1.43B | 0.58% |
| 2021 | 1.42B | 0.40% |
| 2020 | 1.42B | 1.81% |
| 2019 | 1.39B | 0.76% |
| 2018 | 1.38B | 0.80% |
| 2017 | 1.37B | 0.92% |
| 2016 | 1.36B | 2.25% |
| 2015 | 1.33B | 0.26% |
| 2014 | 1.32B | -1.26% |
| 2013 | 1.34B | -4.66% |
| 2012 | 1.41B | -6.80% |
| 2011 | 1.51B | -0.56% |
| 2010 | 1.52B | 0.66% |
| 2009 | 1.51B | 0.63% |
| 2008 | 1.50B | 0.78% |
| 2007 | 1.49B | 16.74% |
| 2006 | 1.27B | 54.14% |
| 2005 | 826.32M | -1.18% |
| 2004 | 836.22M | 0.98% |
| 2003 | 828.07M | 2.12% |
| 2002 | 810.87M | -2.40% |
| 2001 | 830.77M | 2.45% |
| 2000 | 810.87M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 1.74B | 19.98% |
US
|
|
| 1.28B | -11.66% |
IE
|
|
| 382.20M | -73.62% |
US
|
|
| 1.12B | -22.74% |
DE
|
|
| 576.40M | -60.21% |
US
|
Soalan tentang bilangan saham terbitan Boston Scientific Corporation
Berapakah bilangan saham terbitan Boston Scientific Corporation?
Setakat Sep 2026, bilangan saham terbitan Boston Scientific Corporation ialah 1.45B.
Berapakah bilangan saham terbitan Boston Scientific Corporation pada tahun 2025?
Pada tahun 2025, bilangan saham terbitan Boston Scientific Corporation ialah 1.48B, meningkat 0.60% berbanding tahun 2024 (1.47B).
Bagaimanakah bilangan saham terbitan Boston Scientific Corporation berubah sejak tahun 2020?
Dari tahun 2020 hingga 2025, bilangan saham terbitan Boston Scientific Corporation meningkat daripada 1.42B kepada 1.48B, iaitu pertumbuhan purata 0.88% setahun.